home / stock / fold / fold news


FOLD News and Press, Amicus Therapeutics Inc. From 05/07/20

Stock Information

Company Name: Amicus Therapeutics Inc.
Stock Symbol: FOLD
Market: NASDAQ
Website: amicusrx.com

Menu

FOLD FOLD Quote FOLD Short FOLD News FOLD Articles FOLD Message Board
Get FOLD Alerts

News, Short Squeeze, Breakout and More Instantly...

FOLD - Amicus Therapeutics, Inc. 2020 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Amicus Therapeutics, Inc. in conjunction with their 2020 Q1 earnings Read more ...

FOLD - Amicus Therapeutics EPS misses by $0.07, beats on revenue

Amicus Therapeutics (NASDAQ: FOLD ): Q1 GAAP EPS of -$0.35 misses by $0.07 . More news on: Amicus Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

FOLD - Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates

Galafold 1Q2020 Revenue of $60.5 Million Reflects Continued Strong Adoption in All Key Global Regions, On Track to Achieve 2020 Revenue Guidance of $250M-$260M AT-GAA in Late-Onset Pompe Disease Granted Rolling BLA Submission by U.S. FDA CLN3 Batten Disease Gene The...

FOLD - UPDATE - Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting

CRANBURY, N.J., May 06, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases today announced the acceptance of several abstracts for presentation at t...

FOLD - Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting

CRANBURY, N.J., May 05, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases today announced the acceptance of several abstracts for presentation at t...

FOLD - ClearBridge Small Cap Strategy Portfolio Manager Commentary Q1 2020

Source : Read more ...

FOLD - Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020

CRANBURY, N.J., April 24, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 7, 2020 at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2020. The ...

FOLD - Coronavirus Roundtable - Strains And Hopes In The Healthcare Sector

The coronavirus outbreak and the effects of COVID-19 have gone deeper and wider than most people would have expected. That applies just as much to markets as anywhere. Whether it's a tech sector that is supporting our new work from home or re-rating as expensive EV/Sales multiples make less se...

FOLD - XBI: Biotech ETF Expected To Outperform During And After The Coronavirus Pandemic

As the health crisis spirals into a financial one, the liquidation and panic selling have indiscriminately hit sectors across the board. The biotechs were no exception, with the S&P Biotech ETF ( XBI ) plummeting -20% on the year in tandem with the S&P 500 (SPY). Source: WingCapital...

FOLD - 3 Covid-19 Proof Biotech Stocks

That which is common to the greatest number has the least care bestowed upon it, everybody is more inclined to neglect the duty which he expects another to fulfill.” - Aristotle, Politics Markets stabilized somewhat last week after a month of Wuhan coronavirus or Covid-19-trigge...

Previous 10 Next 10